Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.
Continua a leggere "FDA expands use of Prevnar 13 vaccine for people ages 50 and older" »